In supportive oncology and hospital dentistry, mitigating treatment-induced oral complications remains one of the most critical determinants of patient quality of life and therapeutic continuity.
Both systemic chemotherapy and head and neck radiotherapy profoundly disrupt mucosal integrity, salivary gland physiology, and the local oral microenvironment.
Patients frequently endure severe secondary toxicities—ranging from debilitating Oral Mucositis and rapid radiation-induced caries to Xerostomia, opportunistic infections, and the threat of Osteoradionecrosis.
When oral complications escalate, severe pain, dysphagia, and systemic infection risks often necessitate delays, dose reductions, or abrupt interruptions in antineoplastic therapy.
To counteract this rapid deterioration, implementing structured, evidence-based preventive dental protocols prior to and during cancer treatment has emerged as an indispensable clinical standard.
This blog post explores a comprehensive systematic review and meta-analysis published in Diseases (MDPI), which quantitatively evaluates how tailored preventive interventions—including rigorous plaque control, fluoridation strategies, antiseptic biofilm management, and interdisciplinary monitoring—impact oral health outcomes such as the Gingival Index (GI), Plaque Index (PI), and caries incidence in patients undergoing chemotherapy or radiotherapy.
► PDF: Oral Cancer Care & Functional Rehabilitation: Multidisciplinary Oral Health Management Protocols
Key Clinical Insights from the Review
✔ Maintenance of Periodontal and Gingival Health
Pooled meta-analytic data demonstrates that implementing structured preventive regimens stabilizes the Gingival Index (GI) over 6- to 12-month follow-up periods.
Rather than experiencing progressive periodontal breakdown during intensive oncology regimens, patients receiving systematic dental care maintained stable gingival conditions without significant deterioration.
✔ Pre-Therapy Dental Clearance
Proactive pre-treatment screening is paramount. Identifying and resolving odontogenic foci of infection (such as active Periapical Lesions, non-restorable teeth, and advanced Periodontitis) prior to initiating Radiotherapy or Myelosuppressive Chemotherapy substantially lowers the incidence of treatment breaks and life-threatening systemic bacteremia.
✔ Protection of Salivary and Hard Tissue Integrity
Salivary hypofunction resulting from radiotherapy fundamentally diminishes oral clearance, buffering capacity, and mineral saturation.
Structured prophylaxis—combining high-concentration Topical Fluorides, non-irritating antimicrobial mouth rinses, and specialized oral hygiene aids—serves as the primary barrier against aggressive cervical and incisal radiation caries.
✔ Interdisciplinary Oncological Coordination
The synthesis highlights that optimal patient outcomes depend on close alignment between the dental team and medical oncologists.
Standardized oral hygiene regimens, regular chairside monitoring, and individualized patient education must be embedded directly into routine cancer care pathways.
Clinical Pearl
Preventive oral care for oncological patients must never be viewed as an elective afterthought; it is an active clinical countermeasure against oncological treatment interruptions.
Establishing rigorous dental clearance before initiating antineoplastic therapy—paired with continuous, atraumatic biofilm and fluoride protocols during treatment—safeguards oral tissues, protects systemic health, and ensures the oncological treatment plan proceeds without compromise.
📖 Discover the Full Article: Gain full access to the complete meta-analysis data, comparative clinical indices, risk-of-bias assessments, and evidence-based preventive algorithms compiled by the authors.
Click the link below to view, read, and download the complete open-access article in PDF format directly from MDPI.
